Patient-Derived Non-Muscular Invasive Bladder Cancer Xenografts of Main Molecular Subtypes of the Tumor for Anti-Pd-l1 Treatment AssessmentЕкатерина Блинова, А. Д. Каприн, Д А Рощин et al.|Cells|2019Cited by 19
Prognostic Role of FGFR3 Expression Status and Tumor-Related MicroRNAs Level in Association with PD-L1 Expression in Primary Luminal Non-Muscular Invasive Bladder CarcinomaЕкатерина Блинова, Д. В. Перепечин, Evgenia Shich et al.|Life|2020Cited by 13
Cerium-Containing N-Acetyl-6-Aminohexanoic Acid Formulation Accelerates Wound Reparation in Diabetic AnimalsЕкатерина Блинова, Elena G. Lobanova, Dmitry Pakhomov et al.|Biomolecules|2021Cited by 8
Relapse-Free Survival and PD-L1 Expression in First High- and Low-Grade Relapsed Luminal, Basal and Double-Negative P53-Mutant Non-Muscular Invasive Bladder Cancer Depending on Previous Chemo- and ImmunotherapyЕкатерина Блинова, Д. В. Перепечин, Dmitry Enikeev et al.|Cancers|2020Cited by 8
Neural network-based segmentation model for breast cancer X-ray screeningRozhkova Ni, A. Sokolov, Pavel G. Roitberg et al.|Sechenov Medical Journal|2021Cited by 7